ArticleInflammatory bowel diseases2021

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.

Renske W M Pauwels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.